...
机译:碳水化合物抗原19-9水平作为局部晚期胰腺癌整体存活的预后标志物,同时进行化学疗法治疗
Department of Radiation Oncology Ewha Womans University School of Medicine;
Department of Radiation Oncology Konkuk University School of Medicine;
Department of Radiation Oncology Seoul National University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Department of Internal Medicine Ewha Womans University School of Medicine;
Department of Radiation Oncology Ewha Womans University School of Medicine;
Locally advanced pancreatic cancer; CA19-9; Concurrent chemoradiotherapy;
机译:碳水化合物抗原19-9水平作为局部晚期胰腺癌整体存活的预后标志物,同时进行化学疗法治疗
机译:糖抗原19-9在不可切除的局部晚期胰腺癌中的预后意义,所述胰腺癌接受剂量递增的调强放射治疗和同时全剂量吉西他滨治疗:前瞻性1/2期剂量递增研究的分析
机译:化学放疗后CA 19-9水平的变化可预测局部晚期不可切除胰腺癌患者的生存率
机译:NKI-CCRT语料库-伴随放化疗治疗晚期头颈癌前后的语音清晰度
机译:端粒DNA含量和hTERTmRNA水平是乳腺癌和前列腺癌的新的预后标志物。
机译:前瞻性1/2期剂量递增研究分析:糖类抗原19-9不能切除的局部晚期胰腺癌的治疗随剂量逐步升高调强放射治疗和并发全剂量化疗的预后意义
机译:碳水化合物抗原19-9的变化作为临床中临床和局部晚期胰腺癌患者新辅助化疗后的预后标志物